Remove 2021 Remove Marketing Remove Safety
article thumbnail

A comment on the 2024 EWG Sunscreen Guide; Is EWG actively harming safe consumer sun protection?

The Eco Well Blog

Or are they putting these guides out as a fear marketing campaign to promote the EWG seal program (which makes them money)? But hopefully it gives you the gist of why it’s unreliable and why I’ve come to the conclusion that these guides are part of a greater marketing campaign by the EWG. market while tests are still being conducted.

article thumbnail

The Current State of Animal Testing in Beauty - Blog Version

The Eco Well Blog

There is so much misinformation about animal testing in the beauty sector, and a lot of opportunistic, probably predatory, marketing to take advantage. This is especially untrue now with the 2021 animal testing ammendments. Historically animals have been used as an indicator of safety. As far back as 2014, this hasn’t been true.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 Best Nasal Sprays for COVID-19 (2023)

Aesthetics Advisor

In March 2021 , Xlear filed a Pre-Emergency Use Authorization request with the U.S. Canadian biotech SaNOtize’s nitric oxide nasal spray Enovid became available in pharmacies in Israel in July 2021 as a treatment for Covid-19. The pharmacology, toxicity, and safety data for NO use in humans has been well-established for decades.

article thumbnail

Aesthetic Medicine Trends

AAAMS

the world’s premier corporate consulting firm and the definitive source for all things business, recently devoted an in-depth article to the rapid growth of the global aesthetic medicine market size. Explore current and upcoming aesthetic medicine trends, common procedures and more to learn how you can capitalize on this thriving market.

article thumbnail

Biosimilar Watch: FDA Accepts BLA for Proposed Stelara Biosimilar 

The Dermatology Digest

The clinical results demonstrated that DMB-3115 and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of quality, safety and efficacy. market during the next five years. As a global subsidiary of Intas Pharmaceuticals, Accord BioPharma will be responsible for U.S.

article thumbnail

The New Neurotoxin Dosing Paradigm

The Dermatology Digest

DAXI will get an approval, most likely, for the longest acting toxin that we’ve had on the market.” In anticipation of this longer lasting duration, other brands are clinically testing higher doses for safety, efficacy, and patient satisfaction.

article thumbnail

Professional Microdermabrasion Deep Dive

California Skincare Supply

In 2021, professional microdermabrasion machines seemed to continue to hold their own against other popular exfoliation modalities in terms of efficacy for addressing a plethora of skincare concerns. Your Go-To Marketing Tagline for Estheticians Ready for precision exfoliation? Or did it ever really go out of style?